Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Cecilie Hveding Blimark, Kristina Carlson, Christopher Day, Sigrun Einarsdottir, Gunnar Juliusson, Moshtak Karma, Dorota Knut-Bojanowska, Gunnar Larfors, Ingemar Turesson, Mariana Villegas Scivetti, Ingigerdur Sverrisdottir

Blood (2023) 142 (Supplement 1): 4696.

https://doi.org/10.1182/blood-2023-174228

Published: 2023

Journal Articles

Income and Education Affect Prognosis and Treatment in Symptomatic Myeloma: A Population-Based Study on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Gunnar Larfors, Kristina Elisabet Carlson, Christopher Day, Sigrun Einarsdottir, Gunnar Juliusson, Moshtak Karma, Dorota Knut-Bojanowska, Ingigerdur Sverrisdottir, Ingemar Turesson, Mariana Villegas Scivetti, Cecilie Hveding Blimark

Blood (2023) 142 (Supplement 1): 4723.

https://doi.org/10.1182/blood-2023-180637

Published: 2023

Journal Articles

Vaccine-Preventable Infections in Multiple Myeloma: A Population-Based Study on 8672 Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Sigrun Einarsdottir, Ingigerdur Sverrisdottir, Mariana Villegas Scivetti, Christopher Day, Ingemar Turesson, Gunnar Juliusson, Kristina Elisabet Carlson, Gunnar Larfors, Cecilie Hveding Blimark

Blood (2023) 142 (Supplement 1): 4704.

https://doi.org/10.1182/blood-2023-184444

Published: 2023

Journal Articles

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Urvi A Shah, MD, Sæmundur Rögnvaldsson, BS, Andriy Derkach, PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Yael David, PhD, Malin Hultcrantz, MD PhD, Carlyn Tan, MD, Hani Hassoun, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Sham Mailankody, MBBS, Sigurður Yngvi Kristinsson, MD PhD, Ola Landgren, MD PhD

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-141597

Published: 2020

Journal Articles

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Ljupco Veskovski, MD, Per-Ola Andersson, MD PhD, Ingemar Turesson, MD PhD, Daniel Malmodin, PhD, Anders Pedersen, PhD, Ulf-Henrik Mellqvist, MD PhD

Blood (2019) 134 (Supplement_1): 1771.

https://doi.org/10.1182/blood-2019-121961

Published: 2019

Journal Articles

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2019) 134 (Supplement_1): 5444.

https://doi.org/10.1182/blood-2019-131514

Published: 2019

Journal Articles

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

Gudbjorg Jonsdottir, MD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS, MD FRCPath, MRCP, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4437.

https://doi.org/10.1182/blood-2018-99-111715

Published: 2018

Journal Articles

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Sigrun Thorsteinsdottir, MD, Ingigerdur S Sverrisdottir, MD, Gauti Gislason, MSc, Ola Landgren, MD PhD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2018-99-115403

Published: 2018

Journal Articles

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, BS, Sigrun Thorsteinsdottir, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 1914.

https://doi.org/10.1182/blood-2018-99-116740

Published: 2018

Journal Articles

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Gudbjorg Jonsdottir, MD, Magnus Bjorkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Ola Landgren, MD PhD, Sigurdur Y. Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4396.

https://doi.org/10.1182/blood.V130.Suppl_1.4396.4396

Published: 2017

Journal Articles

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4338.

https://doi.org/10.1182/blood.V130.Suppl_1.4338.4338

Published: 2017

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

Journal Articles

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Shaji Kumar, MD, Meletios A Dimopoulos, Efstathios Kastritis, MD, Evangelos Terpos, Hareth Nahi, Hartmut Goldschmidt, MD, Jens Hillengass, MD, Xavier Leleu, Meral Beksac, MD, Melissa Alsina, MD, Albert Oriol, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Maria Victoria Mateos, Elizabeth K. O'Donnell, MD, Ravi Vij, MD MBA, Henk M. Lokhorst, MD PhD, Niels W.C.J. van de Donk, MD PhD, Chang-Ki Min, Tomer Mark, MD MSc, Ingemar Turesson, MD, PhD, Markus Hansson, MD, Heinz Ludwig, Sundar Jagannath, MD, Michel Delforge, MD PhD, Charalampia Kyriakou, MD PhD, Parameswaran Hari, MBBS, MD MRCP, Ulf-Henrik Mellqvist, MD PhD, Saad Z Usmani, MD FACP, Dominik Dytfeld, MD PhD, Ashraf Z Badros, MD, Philippe Moreau, Kihyun Kim, MD PhD, Paula Rodriguez Otero, MD, Jae Hoon Lee, MD, Chaim Shustik, MD, Daniel Waller, PhD, Wee Joo Chng, MD PhD, Shuji Ozaki, MD PhD, Je-Jung Lee, Javier de la Rubia, Hyeon Seok Eom, MD PhD, Laura Rosinol, MD PhD, Juan José Lahuerta, MD PhD, Anna Sureda, MD PhD, Jin Seok Kim, MD PhD, Brian G.M. Durie, MD

Blood (2016) 128 (22): 4414.

https://doi.org/10.1182/blood.V128.22.4414.4414

Published: 2016

Journal Articles

Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival

Vilhjálmur Steingrímsson, Sigrún Helga Lund, Ingemar Turesson, Lynn R. Goldin, Magnus Björkholm, Ola Landgren, Sigurdur Y. Kristinsson

Blood (2015) 125 (13): 2174–2175.

https://doi.org/10.1182/blood-2015-01-622068

Published: 2015

Journal Articles

GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels Are Associated with Multiple Myeloma Bone Disease

Marita Westhrin, MSc, Siv Helen Moen, PhD, Toril Holien, PhD, Oddrun Elise Olsen, MSc, Anne Kærsgaard Mylin, MDhD, Peter Gimsing, MD PhD, Ingemar Turesson, MD PhD, Anders Waage, MD PhD, Therese Standal, PhD

Blood (2014) 124 (21): 2065.

https://doi.org/10.1182/blood.V124.21.2065.2065

Published: 2014

Journal Articles

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Sigrun Helga Lund, PhD, Malin Hultcrantz, MDPhD, Lynn Goldin, PhD, Ola Landgren, MD PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Sigurdur Y Kristinsson, MD, Ph., D

Blood (2014) 124 (21): 3350.

https://doi.org/10.1182/blood.V124.21.3350.3350

Published: 2014

Journal Articles

Robust isolation of malignant plasma cells in multiple myeloma

Ildikó Frigyesi, Jörgen Adolfsson, Mina Ali, Mikael Kronborg Christophersen, Ellinor Johnsson, Ingemar Turesson, Urban Gullberg, Markus Hansson, Björn Nilsson

Blood (2014) 123 (9): 1336–1340.

https://doi.org/10.1182/blood-2013-09-529800

Published: 2014

Includes: Supplemental data

Journal Articles

Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden

Ingemar Turesson, Stephanie A. Kovalchik, Ruth M. Pfeiffer, Sigurdur Y. Kristinsson, Lynn R. Goldin, Mark T. Drayson, Ola Landgren

Blood (2014) 123 (3): 338–345.

https://doi.org/10.1182/blood-2013-05-505487

Published: 2014

Includes: Supplemental data

Journal Articles

Impact Of History Of Autoimmune Disease On Survival In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance: A Population-Based Study

Ebba K Lindqvist, MD, PhD Student, Ingemar Turesson, MD, PhD, Ola Landgren, MD, PhD, Sigrún H Lund, PhD, Lynn Goldin, PhD, Magnus Bjorkholm, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1898.

https://doi.org/10.1182/blood.V122.21.1898.1898

Published: 2013

Journal Articles

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Cecilie Blimark, MD, Erik Holmberg, PhD, Gunnar Juliusson, MD, PhD, Hareth Nahi, MD, PhD, Forsberg Karin, MD, PhD, Ingemar Turesson, MD, PhD, Lucia Ahlberg, MD., PhD., Ronald Svensson, MD, Olle Linder, MD, Kristina Carlsson, MD, PhD, Sigurdur Y Kristinsson, M.D., Ph.D.

Blood (2013) 122 (21): 1972.

https://doi.org/10.1182/blood.V122.21.1972.1972

Published: 2013

NARROW

Risk of Infections in Multiple Myeloma in the Era of Novel Agents, a Population-Based Study Based on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Income and Education Affect Prognosis and Treatment in Symptomatic Myeloma: A Population-Based Study on 8672 Multiple Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Vaccine-Preventable Infections in Multiple Myeloma: A Population-Based Study on 8672 Myeloma Patients Diagnosed 2008-2021 from the Swedish Myeloma Registry

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Serum Metabolomic Profiling Correlated with ISS and Clinical Outcome for Multiple Myeloma Patients Treated with High Dose Melphalan and Autologous Stem Cell Transplantation

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival

GDF15 Promotes Osteoclast Differentiation and High Serum GDF15 Levels Are Associated with Multiple Myeloma Bone Disease

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Robust isolation of malignant plasma cells in multiple myeloma

Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden

Impact Of History Of Autoimmune Disease On Survival In Multiple Myeloma and Monoclonal Gammopathy Of Undetermined Significance: A Population-Based Study

Real World Data In Myeloma: Experiences From The Swedish Population-Based Registry On 2494 Myeloma Patients Diagnosed 2008-2011

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only